Authors
Loading...
This review highlights the tumor necrosis factor receptor superfamily's role in cancer progression and therapeutic strategies, indicating its potential as a target in treatment plans.
Jiayi Xu (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: